Therapeutic Goods Administration (TGA) access pathways in Australia allow registered healthcare practitioners to apply for access to certain unapproved medicines where clinically appropriate and permitted under Australian regulatory frameworks.
The TGA is Australia’s national regulator for medicines and medical products. Most prescription medicines available in Australia are listed on the Australian Register of Therapeutic Goods (ARTG), meaning they have been assessed by the TGA for quality, safety, and effectiveness before being supplied to patients.
In some cases, a healthcare practitioner may determine that a medicine not currently registered on the ARTG may be clinically appropriate for a patient. While these medicines have not been assessed by the TGA for quality, safety, or efficacy, there are established access pathways that allow approved healthcare practitioners to prescribe them under specific regulatory conditions.
Understanding how TGA access pathways work can help patients better understand the clinical assessment process, why additional approvals may be required, and how treatment decisions are made in Australia.
What are TGA access pathways in Australia?
TGA access pathways are regulatory frameworks that allow registered medical practitioners to prescribe certain treatments that are not included on the ARTG, where clinically appropriate.
Doctors must assess each patient individually and determine whether a treatment pathway is suitable based on their clinical needs.
What is the Special Access Scheme (SAS)?
The Special Access Scheme (SAS) is a TGA pathway that allows doctors to apply for access to certain unapproved treatments on behalf of a patient in specific circumstances.
Under this scheme, a doctor submits an application to the TGA outlining why the treatment may be appropriate for the patient. The application considers factors such as medical history, current symptoms, and previous treatments.
Approval is determined based on regulatory requirements and clinical justification.
What is the Authorised Prescriber (AP) pathway?
The Authorised Prescriber pathway allows approved medical practitioners to prescribe specific treatments to a defined group of patients without submitting individual applications for each patient.
This differs from the Special Access Scheme (SAS), where a doctor is typically required to submit an application to the TGA for each individual patient.
This pathway can streamline access for patients who meet the relevant criteria, while still maintaining clinical oversight and regulatory compliance.
How do doctors determine eligibility?
Doctors determine eligibility through an individual clinical assessment. Your medical practitioner must be registered with the Australian Health Practitioner Regulation Agency (AHPRA) and hold the appropriate qualifications to prescribe under the relevant pathway.
This assessment may include:
- a review of your medical history
- an understanding of your current symptoms
- consideration of previous treatments and outcomes
- evaluation of potential risks and suitability
Your medical practitioner is required to ensure that any treatment decision is appropriate and tailored to your individual circumstances, and that you give informed consent to the proposed treatment plan.
Why are these pathways important for patient safety?
TGA access pathways exist to ensure that patient access to unapproved treatments is guided by clinical expertise, informed consent, and regulatory oversight.
This structured approach supports the integrity of the healthcare system (Source: A).
How does telehealth support access to care?
Telehealth allows patients to begin the process of clinical assessment remotely, making it easier to access care regardless of location.
Telehealth consultations are available nationally across Australia, helping patients access healthcare services remotely through secure online consultations.
In many cases, this may involve an initial conversation with a qualified nurse, followed by a doctor assessment if appropriate. From there, a doctor may determine an appropriate treatment plan, subject to applicable regulatory approvals. Read our article on why your first consultation is with a nurse.
What should you expect when exploring treatment pathways?
Exploring treatment pathways typically involves a structured clinical assessment process that helps healthcare practitioners determine whether a treatment pathway may be appropriate for your individual circumstances.
Patients can expect:
- an initial assessment of symptoms and medical history
- a structured clinical review
- clear communication about suitability and next steps
- ongoing monitoring where appropriate
This approach ensures that decisions are made carefully and with patient wellbeing at the centre.
When should you speak to a healthcare professional?
You should speak with a healthcare professional if you have ongoing symptoms, questions about treatment options, or would like to better understand what healthcare pathways may be appropriate for your circumstances.
Ready to take the next step? If you would like to learn more about Alternaleaf and whether our services may be appropriate for your needs, you can book an initial nurse consultation online.
Disclaimer
Alternaleaf does not offer GP or specialist services. Alternaleaf offers alternative health services only. Eligibility for a healthcare pathway is determined by a registered medical practitioner during a clinical assessment.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
